Researchers image iron distribution in Alzheimer brains

An Aussie chemist exploring the role of iron levels in Alzheimer’s disease has led an international effort to map these levels in deceased brains and compare them with iron levels in non-Alzheimer’s brains.

Dominic Hare, PhD, of University of Technology Sydney, and colleagues are using an imaging method called laser ablation inductively coupled plasma-mass spectrometry.

Hare said the technique functions “like a microscope for metals, allowing you to see how elements such as iron are distributed at the near-cellular level.”

Collaborator Erika Raven, a PhD candidate at Georgetown, says this imaging option is sensitive and specific toward iron. “This is especially important in the study of Alzheimer's disease,” she added, “where investigating iron deposition may contribute toward our understanding of iron imbalances in disease pathology.”

Medical Xpress has the story: 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.